Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.220
+0.070 (3.26%)
At close: Jun 6, 2025, 4:00 PM
2.250
+0.030 (1.35%)
After-hours: Jun 6, 2025, 7:58 PM EDT

Oramed Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2021 2016 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2016 - 2020
Revenue
2-1.342.72.712.7
Upgrade
Revenue Growth (YoY)
196.74%--50.42%-0.33%0.33%-0.33%
Upgrade
Cost of Revenue
1.99-----
Upgrade
Gross Profit
0.01-1.342.72.712.7
Upgrade
Selling, General & Admin
6.986.468.1415.6612.585.94
Upgrade
Research & Development
7.356.328.9727.6427.1120.99
Upgrade
Operating Expenses
14.3312.7817.1143.339.6926.93
Upgrade
Operating Income
-14.32-12.78-15.77-40.6-36.98-24.22
Upgrade
Interest Expense
-0.26-0.85-2.04---
Upgrade
Interest & Investment Income
4.5258.173.570.470.35
Upgrade
Currency Exchange Gain (Loss)
0.170.17-0.120.18-0.03-0
Upgrade
Other Non Operating Income (Expenses)
-0.04-0.04-1.54-0.01-0.01-0.01
Upgrade
EBT Excluding Unusual Items
-9.93-8.5-11.3-36.86-36.55-23.88
Upgrade
Gain (Loss) on Sale of Investments
-14.58-7.4216.39-0.81-0.220.9
Upgrade
Pretax Income
-24.51-15.925.09-37.66-36.77-22.99
Upgrade
Income Tax Expense
3.773.18-0.1--
Upgrade
Earnings From Continuing Operations
-28.28-19.15.09-37.76-36.77-22.99
Upgrade
Minority Interest in Earnings
0.040.040.441.21.760.75
Upgrade
Net Income
-28.24-19.065.53-36.56-35-22.24
Upgrade
Net Income to Common
-28.24-19.065.53-36.56-35-22.24
Upgrade
Shares Outstanding (Basic)
414140393728
Upgrade
Shares Outstanding (Diluted)
414141393728
Upgrade
Shares Change (YoY)
-0.05%0.65%4.02%5.08%30.36%16.71%
Upgrade
EPS (Basic)
-0.69-0.470.14-0.94-0.94-0.78
Upgrade
EPS (Diluted)
-0.71-0.480.14-0.94-0.94-0.78
Upgrade
Free Cash Flow
-10.47-8.43-10.55-28.41-33.39-21.56
Upgrade
Free Cash Flow Per Share
-0.26-0.21-0.26-0.73-0.90-0.76
Upgrade
Gross Margin
0.65%-100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-715.95%--1176.79%-1501.96%-1363.50%-896.15%
Upgrade
Profit Margin
-1411.90%-412.31%-1352.61%-1290.71%-822.72%
Upgrade
Free Cash Flow Margin
-523.70%--787.24%-1051.20%-1231.31%-797.48%
Upgrade
EBITDA
-14.15-12.59-15.57-40.54-36.92-24.15
Upgrade
D&A For EBITDA
0.170.190.20.060.050.08
Upgrade
EBIT
-14.32-12.78-15.77-40.6-36.98-24.22
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q